PHARMAnetwork logo
GLOBAL CDMO & PHARMA OUTSOURCING  
Menu
  • Industry Insights
    • Market Intelligence
    • Corporate Strategy
    • Investments & Capex
    • Finance & M&A
    • Regulatory Affairs
    • Legal & Compliance
  • Magazine
    • Latest Issue
    • Archive
    • Editions
    • Editorial Line
  • Events
  • For advertisers
    • Why PHARMAnetwork
    • MediaKit
    • Contact us
  • About PHARMAnetwork
    • Who We Are
    • Editorial Philosophy
    • Contact us

PHARMAnetwork magazine - last issue

PHARMAnetwork magazine: n°68 April 2026 - Content

Market Intelligence
8 Injectable Delivery: A Breakthrough Innovation
Euroject®: a BFS-based singledose injection platform developed by Unither Pharmaceuticals
Corporate Strategy
18 Rethinking Pharmaceutical Manufacturing
Onshoring Opportunities for U.S. Manufacturing.
30 Commercialization as the New Competitive Filter How regulatory evolution and pipeline expansion are redefining biologics manufacturing.
36 CordenPharma: Strategy and Vision in the Polypeptide Market
Finance & M&A
40 Listed CDMOs: Analysis of Financial Performance and Value Dynamics
Legal
60 Geopolitical Context and Supply Tensions: Revealing Contractual Fragilities
Opinion
64 The Increasing valuation of Chinese Licensing Deals Shows a Shift in the Sourcing of Innovation
66 Essential vs. Innovative: The New Pharma Divide
Read our last issue

PHARMAnetwork

  • About us
  • Editorial Philosophy
  • Contact

Editorial content

  • Industry Insights
  • Magazine - last issue
  • Events

For advertisers

  • Why PHARMAnetwork
  • Contact us
© 1997-2026 PHARMAnetwork – All rights reserved.
Privacy Policy | Terms of Use
International media on CDMOs & Contract pharmaceutical